GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » Cyclically Adjusted PB Ratio

IQVIA Holdings (LTS:0JDM) Cyclically Adjusted PB Ratio : 8.83 (As of May. 17, 2024)


View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings Cyclically Adjusted PB Ratio?

As of today (2024-05-17), IQVIA Holdings's current share price is $235.23. IQVIA Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $26.63. IQVIA Holdings's Cyclically Adjusted PB Ratio for today is 8.83.

The historical rank and industry rank for IQVIA Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0JDM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.28   Med: 10.55   Max: 16.99
Current: 8.76

During the past years, IQVIA Holdings's highest Cyclically Adjusted PB Ratio was 16.99. The lowest was 7.28. And the median was 10.55.

LTS:0JDM's Cyclically Adjusted PB Ratio is ranked worse than
90.98% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 2 vs LTS:0JDM: 8.76

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

IQVIA Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $34.819. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $26.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for IQVIA Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cyclically Adjusted PB Ratio Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 15.90 9.84 9.02

IQVIA Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.91 9.55 7.96 9.02 9.48

Competitive Comparison of IQVIA Holdings's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted PB Ratio falls into.



IQVIA Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

IQVIA Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=235.23/26.63
=8.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IQVIA Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=34.819/131.7762*131.7762
=34.819

Current CPI (Mar. 2024) = 131.7762.

IQVIA Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 -4.890 100.560 -6.408
201409 -4.199 100.428 -5.510
201412 -5.672 99.070 -7.545
201503 -4.901 99.621 -6.483
201506 -5.722 100.684 -7.489
201509 -3.299 100.392 -4.330
201512 -4.724 99.792 -6.238
201603 -3.635 100.470 -4.768
201606 -3.868 101.688 -5.012
201609 -2.625 101.861 -3.396
201612 36.674 101.863 47.444
201703 34.461 102.862 44.148
201706 34.838 103.349 44.421
201709 30.741 104.136 38.901
201712 38.419 104.011 48.675
201803 39.461 105.290 49.388
201806 36.365 106.317 45.073
201809 35.665 106.507 44.127
201812 33.995 105.998 42.262
201903 33.545 107.251 41.216
201906 33.315 108.070 40.623
201909 31.603 108.329 38.443
201912 31.217 108.420 37.942
202003 29.016 108.902 35.111
202006 29.226 108.767 35.409
202009 30.496 109.815 36.595
202012 31.386 109.897 37.635
202103 31.070 111.754 36.636
202106 30.063 114.631 34.559
202109 30.502 115.734 34.730
202112 31.700 117.630 35.512
202203 31.268 121.301 33.968
202206 28.682 125.017 30.233
202209 28.778 125.227 30.283
202212 31.045 125.222 32.670
202303 31.978 127.348 33.090
202306 31.393 128.729 32.136
202309 31.808 129.860 32.277
202312 33.675 129.419 34.288
202403 34.819 131.776 34.819

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (LTS:0JDM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


IQVIA Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (LTS:0JDM) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (LTS:0JDM) Headlines

No Headlines